Chemical modification of beta-glucocerebrosidase inhibitor N-octyl-beta-valienamine: synthesis and biological evaluation of N-alkanoyl and N-alkyl derivatives.

Chemical modification of beta-glucocerebrosidase inhibitor N-octyl-beta-valienamine: synthesis and biological evaluation of N-alkanoyl and N-alkyl derivatives.
复制标题

β-葡萄糖脑苷脂酶抑制剂 N-辛基-β-缬烯胺的化学修饰:N-烷酰基和 N-烷基衍生物的合成和生物学评价。

DOI:
10.1016/s0968-0896(98)00143-6
复制
发表时间:
1998
影响因子:
3.5
通讯作者:
J. Inokuchi
J. Inokuchi
中科院分区:
医学3区
文献类型:
--
作者:
S. Ogawa;Y. Kobayashi;K. Kabayama;M. Jimbo;J. Inokuchi

文献摘要

被引文献

相似文献

合成了β-葡萄糖脑苷脂酶抑制剂N-辛基-β-维列胺(3)的N-烷酰基衍生物4a-d和N-烷基衍生物5a-g,以阐明疏水部分在抑制作用中的作用。虽然前者缺乏抑制效力,但后者是强β-葡糖脑苷脂酶抑制剂(参见N-癸基-N-辛基-β-井冈霉烯胺5d:Ki 6.6 ×10− 8 M)。此外,当将N-丁基-N-辛基-β-井冈霉烯胺5a和5d处方给小鼠来源的B16黑色素瘤细胞时,显示出改变GlcCer和GM 3的量,这表明它们可能被引入细胞并影响糖脂生物合成。
Several N-alkanoyl 4a–d and N-alkyl derivatives 5a–g of the potent β-glucocerebrosidase inhibitor N-octyl β-valienamine (3) were synthesized in order to elucidate a role of hydrophobic portion in the inhibitory action. Although the former lacked inhibitory potency, the latter were strong β-glucocerebrosidase inhibitors (cf. N-decyl-N-octyl-β-valienamine 5d: Ki6.6×10−8M). Furthermore, when being prescribed into mouse-derived B16 melanoma cells, N-butyl-N-octyl-β-valienamine 5a and 5d were shown to change the amount of GlcCer and GM3, which suggests that they are possibly introduced into cells and influence glycolipids biosynthesis.